Observations on Aron et al's "Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3 CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia"

Am J Surg Pathol. 2014 Jul;38(7):1013-5. doi: 10.1097/PAS.0000000000000191.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Biomarkers, Tumor / analysis*
  • Carcinoma in Situ / diagnosis*
  • Carcinoma, Transitional Cell / diagnosis*
  • Humans
  • Urinary Bladder Neoplasms / diagnosis*

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor